CXCL2 and hyperlipidemia: Our research shows that in addition to producing neutrophil chemokines (e.g., CXCL2), hyperlipidemia‐induced metabolic reprogramming in monocytes enhances NETs release through regulatory metabolites, specifically LPC and LPA.[24]